|
Aug 1
|
Are Investors Undervaluing Catalyst Pharmaceuticals (CPRX) Right Now?
|
|
Jul 29
|
Investors in Catalyst Pharmaceuticals (NASDAQ:CPRX) have seen enviable returns of 404% over the past five years
|
|
Jul 28
|
CPRX vs. NBIX: Which Stock Should Value Investors Buy Now?
|
|
Jul 24
|
Zacks.com featured highlights Catalyst Pharmaceuticals, SunOpta, Gambling.com and Orion Group
|
|
Jul 23
|
Rising Cash Flows Make These 4 Stocks Worth Choosing Now
|
|
Jul 22
|
Buy These 4 Stocks With Solid Net Profit Margin to Maximize Returns
|
|
Jul 22
|
Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
|
|
Jul 17
|
Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
|
|
Jul 16
|
Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock?
|
|
Jul 16
|
5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
|
|
Jun 23
|
CPRX vs. NBIX: Which Stock Is the Better Value Option?
|
|
Jun 19
|
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
|
|
Jun 18
|
Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth
|
|
Jun 18
|
Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
|
|
Jun 10
|
Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run?
|
|
May 14
|
The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business
|
|
Apr 11
|
Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?
|
|
Apr 11
|
Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?
|
|
Apr 9
|
Catalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% Dip
|
|
Apr 8
|
Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade
|